The ROI of eRegulatory Whitepaper 2018-03-11T16:48:37+00:00

Free Download: Proving the Return on Investment (ROI) of eRegulatory

Detailed research and insights into how eRegulatory creates measurable financial impacts in clinical trials.

Precision medicine and immunotherapy clinical trials transform research while spiking demand at the research centers best equipped to efficiently conduct them in a compliant way. In parallel to this increasing demand, study volume and protocol complexity are on the rise. These centers need to scale their operations and accelerate trials while remaining compliant.

As a solution to these challenges, tools are emerging for the automation of study tasks, including Florence eBinder Suiteā„¢, but how can a site manager prove that they provide a positive return on investment?

This whitepaper examines six economic drivers paying back the cost of an eRegulatory and eSource platform (eBinders) so that centers can make an informed decision as they scale to advance cures. The findings show that oncology centers can capture nearly $20,000 of benefit per study.

Download Guide